Systemic Infection Treatment Market Drivers, Restraints, Opportunitie Systemic Infection Treatment Healthcare | Page 4

Systemic Infection Treatment Market
Systemic Infection are the type of pathogenic infection that spreads throughout the body. It can be
comprised of bacterial, viral or fungal infections. The main characteristic of systemic infection is affecting
the bloodstream of a person and thus spread to the whole body. The systemic infections can vary from
the common ones such as cold, flu, strep throat or can be life-threatening like STDs. Conventional
methods used for the diagnosis of these type of infections might delay the therapy process. Nowadays,
modern day techniques such as ELISA and PCR are most used for more specific and quick
results. Treatment depends upon the type and severity of infection. Generally, antibacterial, antiviral and
antifungal drugs are given for the treatment by either oral or intravenous mode of administration. Oral
route of administration is the safest, economical and the easiest way of treatment. Nowadays, multi drug
resistance is one of the growing concern for the treatment of pathogens. The treatment becomes difficult
in some cases as infection spreads throughout the body.
By the increased number of people with reduced immune response has led to increased prevalence of
systemic infections. On the other hand, a large number of anti-infectives are available in the market
which thus increase the overall market of systemic infection treatment.
Systemic Infection Treatment Market: Drivers & Restraints
Systemic Infection Treatment market is likely to proliferate in the future as per existing trends for the
increase in the patient pool across the globe. Large number of research studies these days has increased
the number
©2015 Future Market Insights, All Rights Reserved
4